XIENCE Sierra Everolimus Eluting Stent Abbott Coronary Drug-Eluting Stent System

XIENCE Sierra™ Everolimus Eluting Coronary Stent System
The XIENCE Sierra™ Everolimus Eluting Coronary Stent System by Abbott Laboratories is a drug-eluting coronary stent designed for percutaneous coronary intervention (PCI) in patients with coronary artery disease.

Key Features
Stent Platform: Cobalt chromium stent platform for strength, flexibility, and durability
Drug: Everolimus-eluting coronary stent system for PCI procedures
Polymer: Durable fluoropolymer coating designed for controlled drug release
Delivery System: Low-profile balloon-expandable catheter-based system for improved lesion access and crossing
Performance: Designed for enhanced deliverability in complex and tortuous coronary anatomy
Markers: Radiopaque markers for precise positioning under fluoroscopy
Guidewire Compatibility: Compatible with 0.014 in guidewires
Available Sizes: Available in multiple diameters and lengths, including long lesion coverage options
Support: Designed to support uniform expansion and vessel scaffolding

Clinical Applications
Indicated for improving coronary luminal diameter in patients with symptomatic ischemic heart disease due to de novo native coronary artery lesions
Used in PCI procedures to restore blood flow by providing vessel scaffolding and delivering antiproliferative drug therapy to reduce restenosis risk
Suitable for use in complex coronary lesions, including long lesions and small vessels

Product Information
Product Name: XIENCE Sierra™ Everolimus Eluting Coronary Stent System
Brand: Abbott
Manufacturer: Abbott Laboratories
Product Type: Drug-eluting coronary stent system
Stent Material: Cobalt chromium alloy
Clinical Use: Coronary artery disease / PCI procedures
Usage: Single use, sterile